Zymergen Inc.
ZYDelisted Oct 19, 2022- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001645842
Zymergen Inc. was delisted on Oct 19, 2022; its insiders filed their last Form 4 on Oct 21, 2022; 86 institutions reported holding it in 13F filings for Q3 2022, worth $168.1M in total; ARK Invest was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Zymergen Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 82 | 1 | 86 | +5 |
| Shares | 57.5M | 39.5K | 60.4M | +2.94M (+5.1%) |
| Value | $71.4M | $49.0K | $168.1M | +$96.7M (+135.5%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (26)
Institutions that held Zymergen Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (21)
Institutions that held Zymergen Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Two Sigma Ventures, LP | 1,513,727 | $1.86M |
| Perceptive Advisors LLC | 883,332 | $1.09M |
| Renaissance Technologies LLC | 447,167 | $550.0K |
| Two Sigma Investments, LP | 320,013 | $394.0K |
| Marshall Wace, LLP | 181,580 | $223.0K |
| ARCH Venture Management, LLC | 119,205 | $147.0K |
| HRT Financial LP | 107,089 | $131.0K |
| Gsa Capital Partners LLP | 47,264 | $58.0K |
| Laurion Capital Management LP | 29,954 | $37.0K |
| Boothbay Fund Management, LLC | 26,042 | $32.0K |
| Cubist Systematic Strategies, LLC | 23,350 | $29.0K |
| Voloridge Investment Management, LLC | 22,819 | $28.0K |
| Balyasny Asset Management LLC | 17,981 | $22.0K |
| XTX Topco Ltd | 15,131 | $19.0K |
| Wolverine Trading, LLC | 13,765 | $18.0K |
| Bayesian Capital Management, LP | 12,500 | $15.0K |
| Victory Capital Management Inc | 10,723 | $13.0K |
| New York State Common Retirement Fund | 560 | $1.00K |
| Captrust Financial Advisors | 454 | $1.00K |
| Cribstone Capital Management, LLC | 40 | $0 |
| Global Wealth Management Investment Advisory, Inc. | 100 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Zymergen Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| B. Riley Wealth Management, Inc. | 39,500 | $49.0K |